{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:00:40Z","timestamp":1760043640473},"reference-count":38,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T00:00:00Z","timestamp":1091577600000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002<jats:italic>Helicobacter pylori<\/jats:italic> infection has been implicated as a possible cause of extraintestinal disorders such as skin diseases. A number of case reports describe patients with skin diseases, such as prurigo nodularis, that are associated with gastric cancer.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002The aim of this study was to examine the prevalence of <jats:italic>H. pylori<\/jats:italic> infection and the incidence of gastric cancer in patients with pruritic skin diseases.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002The patients were examined for circulating specific IgG antibodies against <jats:italic>H. pylori<\/jats:italic> in sera using ELISA. <jats:italic>H. pylori<\/jats:italic>\u2010positive patients who were more than 40\u2003years old underwent endoscopic screening for gastric cancer.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002We examined 134 patients with pruritic skin diseases, including 55 cases of cutaneous pruritus, 21 cases of prurigo chronica multiforme, 15 cases of nummular dermatitis and 43 cases of chronic urticaria. Early gastric cancer was detected in 2\/36 (5.6%) patients with cutaneous pruritus and 3\/16 (18.8%) with prurigo chronica multiforme. The prevalence of early gastric cancer was 5.6%, which was much higher than that among patients undergoing general endoscopic screening for gastric cancer.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002These results suggest that <jats:italic>H. pylori<\/jats:italic>\u2010positive patients with pruritic skin diseases may be at increased risk for development of gastric cancer, and endoscopic screening in such patients is recommended.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.01977.x","type":"journal-article","created":{"date-parts":[[2004,12,19]],"date-time":"2004-12-19T10:07:02Z","timestamp":1103450822000},"page":"80-84","source":"Crossref","is-referenced-by-count":9,"title":["<i>Helicobacter pylori<\/i>\u2010positive patients with pruritic skin diseases are at increased risk for gastric cancer"],"prefix":"10.1111","volume":"20","author":[{"given":"A.","family":"Shiotani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sakurane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,8,4]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.00770.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(89)80057-5"},{"issue":"2","key":"e_1_2_5_4_2","first-page":"S1","article-title":"Guidelines for clinical trials in Helicobacter pylori infection","volume":"41","author":"Working Party of the European Helicobacter pylori Study Group.","year":"1997","journal-title":"Gut"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(05)70279-0"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199801000-00002"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(00)00131-1"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2001.00009.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350200058"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018851623109"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199703000-00001"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)65386-X"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03612.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.9.925"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026677728175"},{"key":"e_1_2_5_16_2","first-page":"873","article-title":"Pruritus as a manifestation of systemic disorders","volume":"21","author":"Botero F","year":"1978","journal-title":"Cutis"},{"key":"e_1_2_5_17_2","first-page":"2681","article-title":"Pruritus","volume":"45","author":"Klecz RJ","year":"1992","journal-title":"Am Fam Physician"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117732"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1965.01600130042004"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(00)00084-X"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1996.tb02684.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000250965"},{"key":"e_1_2_5_23_2","first-page":"58","article-title":"Cutaneous manifestations of malignant disease","volume":"48","author":"Higgins EM","year":"1992","journal-title":"Br J Hosp Med"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155500750042970"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)32048-X"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70022-L"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70001-A"},{"key":"e_1_2_5_28_2","first-page":"227","article-title":"Cutaneous manifestations of internal malignancy","volume":"20","author":"Rosenberg FW","year":"1977","journal-title":"Cutis"},{"key":"e_1_2_5_29_2","first-page":"773","article-title":"Cutaneous signs of internal malignancy","volume":"57","author":"Shelley WB","year":"1974","journal-title":"Minn Med"},{"key":"e_1_2_5_30_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0095-4543(21)00613-8","article-title":"Paraneoplastic syndromes for the primary care physician","volume":"19","author":"Wallach PM","year":"1992","journal-title":"Prim Care"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb03891.x"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(94)00371-K"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931201)72:11<3174::AID-CNCR2820721107>3.0.CO;2-H"},{"issue":"1","key":"e_1_2_5_34_2","first-page":"A3074","article-title":"High\u2010risk population for stomach cancer detected by serum pepsinogen and antibodies to H. pylori","volume":"120","author":"Kitauchi S","year":"2001","journal-title":"Gastroenterol"},{"key":"e_1_2_5_35_2","first-page":"227","article-title":"Cutaneous manifestations of internal malignancy","volume":"20","author":"Rosenberg FW","year":"1977","journal-title":"Cutis"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(00)00084-X"},{"key":"e_1_2_5_37_2","first-page":"2863","article-title":"Enhanced induction of gastric carcinogenesis by N\u2010methyl\u2010N\u2010nitro\u2010N\u2010nitrosoguanidine in deoxycorticosterone acetate\u2010NaCl hypertensive rats and its inhibition by potassium chloride","volume":"51","author":"Tatsuta M","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.2.301"},{"key":"e_1_2_5_39_2","first-page":"33","article-title":"Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer","volume":"2","author":"Gordon GB","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01977.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01977.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.01977.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:10:17Z","timestamp":1695813017000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.01977.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":38,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1365-2036.2004.01977.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.01977.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}